Thomas W Rampling
Overview
Explore the profile of Thomas W Rampling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Churcher T, Sinden R, Edwards N, Poulton I, Rampling T, Brock P, et al.
PLoS Pathog
. 2017 Jan;
13(1):e1006108.
PMID: 28081253
Over a century since Ronald Ross discovered that malaria is caused by the bite of an infectious mosquito it is still unclear how the number of parasites injected influences disease...
2.
Payne R, Milne K, Elias S, Edwards N, Douglas A, Brown R, et al.
J Infect Dis
. 2016 Feb;
213(11):1743-51.
PMID: 26908756
Background: Models of controlled human malaria infection (CHMI) initiated by mosquito bite have been widely used to assess efficacy of preerythrocytic vaccine candidates in small proof-of-concept phase 2a clinical trials....
3.
Hodgson S, Douglas A, Edwards N, Kimani D, Elias S, Chang M, et al.
Malar J
. 2015 Jan;
14:33.
PMID: 25627033
Background: Controlled human malaria infection (CHMI) studies increasingly rely on nucleic acid test (NAT) methods to detect and quantify parasites in the blood of infected participants. The lower limits of...
4.
Hodgson S, Juma E, Salim A, Magiri C, Kimani D, Njenga D, et al.
Front Microbiol
. 2015 Jan;
5:686.
PMID: 25566206
Background: Controlled human malaria infection (CHMI) studies are a vital tool to accelerate vaccine and drug development. As CHMI trials are performed in a controlled environment, they allow unprecedented, detailed...
5.
Hodgson S, Choudhary P, Elias S, Milne K, Rampling T, Biswas S, et al.
Mol Ther
. 2014 Aug;
22(12):2142-2154.
PMID: 25156127
The development of effective vaccines against difficult disease targets will require the identification of new subunit vaccination strategies that can induce and maintain effective immune responses in humans. Here we...